recommended dosage for ghk-cu peptide injection subcutaneous typical dose how much ghk- cu should i inject weekly GLOW (BPC-157/GHK-CU/KPV/TB500) Injections The tri-peptide GHK-Cu complex ameliorates – GHK-Cu Dosage: A Doctor's Guide

Priority Applications (22) Applications Claiming Priority (2) Related Child Applications (2) Publications (1) Family ID=60478958 Family Applications (1) Country Status (16) Cited By (9) Families Citing this family (1) Citations (6) Family Cites Families (237) 2017 2017-06-01 US US16/306,277 patent/US11021514B2/en active Active 2017-06-01 CA CA3026074A patent/CA3026074A1/en active Pending 2017-06-01 JP JP2019515778A patent/JP2019525947A/en active Pending 2017-06-01 ES ES17807519T patent/ES2912035T3/en active Active 2017-06-01 PL PL17807519T patent/PL3464336T3/en unknown 2017-06-01 CN CN202310097199.3A patent/CN116655730A/en active Pending 2017-06-01 SI SI201731129T patent/SI3464336T1/en unknown 2017-06-01 EP EP22161834.1A patent/EP4067368A1/en not_active Withdrawn 2017-06-01 CN CN202310310636.5A patent/CN116731101A/en active Pending 2017-06-01 HR HRP20220479TT patent/HRP20220479T1/en unknown 2017-06-01 EP EP17807519.8A patent/EP3464336B1/en active Active 2017-06-01 SM SM20220173T patent/SMT202200173T1/en unknown 2017-06-01 RS RS20220383A patent/RS63143B1/en unknown 2017-06-01 AU AU2017273857A patent/AU2017273857B2/en active Active 2017-06-01 CN CN201780046512.3A patent/CN109563144B/en active Active 2017-06-01 LT LTEPPCT/US2017/035547T patent/LT3464336T/en unknown 2017-06-01 DK DK17807519.8T patent/DK3464336T3/en active 2017-06-01 WO PCT/US2017/035547 patent/WO2017210489A1/en not_active Ceased 2021 2021-04-12 US US17/228,481 patent/US12421276B2/en active Active 2021-11-09 AU AU2021266222A patent/AU2021266222B2/en active Active 2021-12-27 JP JP2021211913A patent/JP7203943B2/en active Active 2022 2022-04-20 CY CY20221100295T patent/CY1125184T1/en unknown 2022-12-27 JP JP2022209881A patent/JP2023036883A/en active Pending 2023 2023-12-22 AU AU2023285937A patent/AU2023285937A1/en not_active Abandoned 2024 2024-11-01 JP JP2024192891A patent/JP2025020295A/en active Pending

Both represent a step beyond current FDA-approved options

If deficiency or low-normal levels are contributing, correcting them can improve energy and clarity

Dispatch: In-stock items are prepared within 2448 hours of confirmed payment